A variety of techniques, including use of live oral vaccines, have been employed to deliver antigens to the gutassociated lymphoid tissue in an attempt to initiate production of specific secretory immunoglobulin A (IgA) antibodies. One recent approach has been to employ avirulent derivatives of Salmonella strains as carriers for plasmids which code for virulence determinants of heterologous mucosal pathogens (recently reviewed by Clements [2] ). Antigens expressed by these strains would presumably be delivered directly to the antibody-forming cells in the gutassociated lymphoid tissue. This has been shown to be an effective means of stimulating significant levels of specific mucosal secretory IgA directed against the carrier strain and the heterologous antigen and has been shown to stimulate production of serum antibodies as well (4) .
A number of investigators have employed a variety of Salmonella mutants for this purpose, including galE mutants, which lack the enzyme UDP-galactose-4-epimerase (3, 10-12, 16, 25, 26) , and aroA mutants, which have specific nonreverting deletions in the common aromatic biosynthetic pathway leading to chorismic acid (1, 4, 8, 13, 16, 17, (20) (21) (22) (23) (24) . Deletion mutants of Salmonella typhimurium lacking adenylate cyclase and cyclic AMP receptor protein have also been examined as carriers for antigens of Streptococ-cus mutans in the development of a potential anticaries vaccine (5-7).
Strains of Salmonella typhi attenuated by auxotrophic characters have also been constructed as live-vaccine candidates (9) for immunization against typhoid fever. Two strains recently tested in volunteers (15) strains to be tested in mice to facilitate isolation from tissue: SL7163 (AaroA), SL7165 (ApurA), and SL7164 (AaroA ApurA). As only the three nalidixate-resistant mutants were used in the animal experiments described below, we refer to them below as the aroA, purA, and aroA purA strains rather than by their strain numbers and genotypes, which are given in Table 1 . Colonization, invasion, and persistence in mouse tissues. Studies to determine the abilities of the auxotrophic mutants to colonize the small intestine and to invade and persist in mouse tissues were conducted with groups of 20 female BALB/c mice essentially as previously described (4). On days 1, 3, 7, 8, 14, and 21 postinoculation, three to five animals from each group were sacrificed, and tissues (liver, spleen, blood, Peyer's patches, and small intestine) from each animal were removed aseptically and cultured for the presence of the infecting organism. There was evidence for colonization of the small intestines and invasion of and persistence in mouse tissues only with the aroA strain, which was isolated from the small intestines, Peyer's patches, livers, and spleens of animals up through day 3 postinoculation (Table 2) . Thereafter, only the livers and, beginning at day 8 postinoculation, the small intestines were infected. The aroA strain could be isolated from the blood of only one animal on one day (day 3 postinoculation). Of the 20 animals in this group, the aroA strain was isolated from the small intestines of 9, from the Peyer's patches of 5, from the livers of 7, from the spleens of 2, and from the blood of 1 ( Table 2) .
The purA strain was isolated from the small intestine, liver, and blood of only a single animal and only on day 1 (Table 3 ). There was, however, great variability between individual animals in all groups; statistical differences between values from immunized groups and control values from unimmunized animals were not consistent at 1, 2, or 3 weeks following the primary inoculation. By the end of week 5, serum anti-LPS IgG had increased from 0 to 14.1 ,ug/ml in animals immunized with the aroA strain, a value significantly greater than that obtained after immunization with either the purA strain (2.89 ,ug/ml) or the aroA purA strain (2.37 ,ug/ml).
Less initial variability was observed between animals examined for the presence of mucosal anti-LPS IgA. Mucosal anti-LPS IgA was consistently significantly higher in animals immunized with the aroA strain than in animals from the other two groups ( transduction. As noted previously, the methods used were
